Cryoport Inc
NASDAQ:CYRX
Cryoport Inc
NASDAQ:CYRX
Price:
15.95 USD
-7.05%
Market Closed
Updated:
May 4, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-20.1
Current
-19.6
Median
12.6
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-20.1
Enterprise Value
/
705.2m
EBITDA
-38.1m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| US |
|
Cryoport Inc
NASDAQ:CYRX
|
781.1m USD | -20.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.5B USD | 19.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 55.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.8B USD | 24.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.5B USD | 13.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 30.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 18.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 18.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 26.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.9B USD | 59.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 28.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
-72
2-Years Forward
EV/EBITDA
116.9
3-Years Forward
EV/EBITDA
61.3
You don't have any saved screeners yet
